Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Beuzeboc

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
Clinical Medicine. Oncology|September 6, 2011
Pre-operative Concomitant Radio-chemotherapy in Bulky Carcinoma of the Cervix: A Single Institution StudyAnne de la Rochefordiere, Youlia Kirova, Severine Alran, et al.
European Journal of Cancer (Oxford, England : 1990)|April 15, 2014
Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancerAntoine Angelergues, Denis Maillet, Aude Fléchon, et al.
BMC Cancer|April 18, 2015
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in FranceNadine Houédé, Philippe Beuzeboc, Sophie Gourgou, et al.
Communications Medicine|December 23, 2025
Impact of androgen receptor pathway inhibitors on cognitive function in older adults treated for metastatic prostate cancerAntoine Boué, Giulia Baciarello, Emmanuel Meyer, et al.
Joint Bone Spine|October 6, 2018
French recommendations for osteoporosis prevention and treatment in patients with prostate cancer treated by androgen deprivationKarine Briot, Julien Paccou, Philippe Beuzeboc, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendationsManfred Kaufmann, Gunter von Minckwitz, Roy Smith, et al.
Prostate Cancer and Prostatic Diseases|October 26, 2023
Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancerRobert Hugh Jones, Karim Fizazi, Nicholas D James, et al.
European Journal of Cancer (Oxford, England : 1990)|September 15, 2012
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trialsAllan Lipton, Karim Fizazi, Alison T Stopeck, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 25, 2007
[Prostatic cancers]Michel Soulié, Philippe Beuzeboc, François Cornud, et al.
European Urology|November 28, 2015
Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 TrialGwenaelle Gravis, Jean-Marie Boher, Florence Joly, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Clinical Medicine. Oncology|September 6, 2011
Pre-operative Concomitant Radio-chemotherapy in Bulky Carcinoma of the Cervix: A Single Institution StudyAnne de la Rochefordiere, Youlia Kirova, Severine Alran, et al.
European Journal of Cancer (Oxford, England : 1990)|April 15, 2014
Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancerAntoine Angelergues, Denis Maillet, Aude Fléchon, et al.
BMC Cancer|April 18, 2015
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in FranceNadine Houédé, Philippe Beuzeboc, Sophie Gourgou, et al.
Communications Medicine|December 23, 2025
Impact of androgen receptor pathway inhibitors on cognitive function in older adults treated for metastatic prostate cancerAntoine Boué, Giulia Baciarello, Emmanuel Meyer, et al.
Joint Bone Spine|October 6, 2018
French recommendations for osteoporosis prevention and treatment in patients with prostate cancer treated by androgen deprivationKarine Briot, Julien Paccou, Philippe Beuzeboc, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendationsManfred Kaufmann, Gunter von Minckwitz, Roy Smith, et al.
Prostate Cancer and Prostatic Diseases|October 26, 2023
Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancerRobert Hugh Jones, Karim Fizazi, Nicholas D James, et al.
European Journal of Cancer (Oxford, England : 1990)|September 15, 2012
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trialsAllan Lipton, Karim Fizazi, Alison T Stopeck, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 25, 2007
[Prostatic cancers]Michel Soulié, Philippe Beuzeboc, François Cornud, et al.
European Urology|November 28, 2015
Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 TrialGwenaelle Gravis, Jean-Marie Boher, Florence Joly, et al.
Pageof 13